ThinkSono is a technology company.
ThinkSono has raised $3.9M across 2 funding rounds.
Key people at ThinkSono.
ThinkSono has raised $3.9M in total across 2 funding rounds.
Key people at ThinkSono.
ThinkSono has raised $3.9M in total across 2 funding rounds.
ThinkSono's investors include Ambridge Capital, Badhouse Ventures, Balderton Capital, Calm/Storm Ventures, DST Global, Index Ventures, Jigsaw VC, Lakestar, Pario Ventures, Playfair Capital, QVentures, Sequoia Capital.
ThinkSono is a medtech company developing AI-guided ultrasound software for point-of-care detection of deep vein thrombosis (DVT), a common and dangerous blood clot condition.[1][2][5] Its flagship product, ThinkSono Guidance, overlays real-time AI instructions on standard ultrasound devices, enabling non-experts like nurses or emergency staff to perform accurate scans in minutes, reducing diagnostic delays from days to 15 minutes.[1][5] The system targets healthcare providers in emergency, outpatient, and primary care settings, addressing ultrasound operator shortages and improving access to rapid DVT diagnosis, which affects millions annually. Backed by clinical trials on over 1,000 patients, it holds Class IIb CE marking and MHRA registration in the EU and UK, showing strong regulatory progress and growth potential.[5]
Founded in 2016 in Potsdam, Germany (formerly Khirop Diagnostics), ThinkSono emerged from a mission to democratize ultrasound diagnostics amid healthcare workforce gaps.[1][2] Co-founders Fouad Al-Noor (CEO) and Sven Mischkewitz (CTO) drove the vision: Al-Noor focuses on AI-driven innovation for diagnostics access, while Mischkewitz, with a Bachelor's in IT-Systems Engineering from Hasso-Plattner-Institute, leads technical development.[2] Early traction included the Berlin Brandenburg Innovation Award, validating their AI for non-experts, and association with Entrepreneurs First, signaling investor confidence in their pivot to DVT-specific guidance.[2][4]
Competitors like Butterfly Network offer portable hardware, but ThinkSono differentiates via software-only AI retrofitting any device for DVT focus.[1]
ThinkSono rides the AI-medtech wave, amplifying point-of-care ultrasound amid global clinician shortages and rising DVT incidence from aging populations and post-COVID immobility.[1][5] Timing aligns with regulatory tailwinds like EU MDR approvals and AI health tech investments, positioning it against players like PONS (imaging software) and Butterfly (hardware).[1] Market forces favor it: DVT diagnostics market grows with demand for decentralized care, reducing hospital burdens; its software model scales cheaply versus hardware rivals.[1][5] By enabling frontline staff, ThinkSono influences ecosystems toward AI-augmented workflows, accelerating preventive screening and influencing standards in emergency medicine.[3][5]
ThinkSono is poised for expansion into US FDA clearance and broader indications beyond DVT, leveraging trial data and patents for partnerships with ultrasound giants like Philips.[1][5] Trends like AI democratization in diagnostics and telehealth integration will propel growth, potentially capturing shares in the $2B+ point-of-care ultrasound market. Its influence may evolve from niche innovator to ecosystem enabler, powering accessible scans globally—transforming DVT from a diagnostic bottleneck to a streamlined process, much like its core promise of 15-minute pathways.[5]
ThinkSono has raised $3.9M across 2 funding rounds. Most recently, it raised $3.0M Seed in July 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jul 1, 2020 | $3.0M Seed | Ambridge Capital, Badhouse Ventures, Balderton Capital, Calm/Storm Ventures, DST Global, Index Ventures, Jigsaw VC, Lakestar, Pario Ventures, Playfair Capital, QVentures, Sequoia Capital, Target Global, TCV, Tiger Global Management, Christopher Zemina, Jeff Crusey, Matteo Gamba, Stephen Romanoff | |
| Jan 1, 2018 | $900K Seed | Ambridge Capital, Badhouse Ventures, Balderton Capital, DST Global, Helium-3 Ventures, Index Ventures, Jigsaw VC, Lakestar, Pareto Holdings, Pario Ventures, Playfair Capital, Sequoia Capital, Target Global, TCV, Tiger Global Management, Charlie Songhurst, Christopher Zemina, Jeremy Yap, Matt Bellamy, Matteo Gamba, Stephen Romanoff, Xen Lategan |
